Title |
How Should Representation of Subjects With LEP Become More Equitable in Clinical Trials?
|
---|---|
Published in |
The AMA Journal of Ethic, April 2022
|
DOI | 10.1001/amajethics.2022.319 |
Pubmed ID | |
Authors |
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A O'Brian, Melissa A Simon |
Abstract |
Underrepresentation of individuals with limited English proficiency (LEP) who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity. This article suggests strategies for increasing representation of Spanish speakers in clinical rials by emphasizing the importance of early engagement with Spanish language communities, inclusive participant recruitment, and collaborative trial design and implementation. Although investigators and institutions administering government-funded research must meet federal requirements for language assistance, journal editors, peer reviewers, institutional review board members, academic health centers, and all beneficiaries of the biomedical and behavioral research enterprise in the United States must motivate linguistic inclusion. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 88% |
Unknown | 1 | 13% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Practitioners (doctors, other healthcare professionals) | 2 | 25% |
Scientists | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 1 | 17% |
Student > Doctoral Student | 1 | 17% |
Unknown | 4 | 67% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 1 | 17% |
Materials Science | 1 | 17% |
Unknown | 4 | 67% |